Chao Hu

522 total citations
37 papers, 374 citations indexed

About

Chao Hu is a scholar working on Molecular Biology, Neurology and Pharmacology. According to data from OpenAlex, Chao Hu has authored 37 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Neurology and 6 papers in Pharmacology. Recurrent topics in Chao Hu's work include Prion Diseases and Protein Misfolding (18 papers), Neurological diseases and metabolism (8 papers) and RNA regulation and disease (5 papers). Chao Hu is often cited by papers focused on Prion Diseases and Protein Misfolding (18 papers), Neurological diseases and metabolism (8 papers) and RNA regulation and disease (5 papers). Chao Hu collaborates with scholars based in China, Singapore and United States. Chao Hu's co-authors include Qiongming Xu, Ziyu Zhang, Yanli Liu, Shilin Yang, Hongwei Gao, Naixin Kang, Cao Chen, Qi Shi, Kang Xiao and Jia Miao and has published in prestigious journals such as Journal of Ethnopharmacology, Neurobiology of Aging and Medicine.

In The Last Decade

Chao Hu

35 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao Hu China 11 183 65 50 50 42 37 374
Hailiang Huang China 11 178 1.0× 55 0.8× 14 0.3× 45 0.9× 32 0.8× 43 457
Yuting Yang China 11 123 0.7× 36 0.6× 51 1.0× 27 0.5× 41 1.0× 29 307
Hechen Zhu China 10 114 0.6× 24 0.4× 13 0.3× 52 1.0× 38 0.9× 18 340
Yang Mei-juan China 10 130 0.7× 34 0.5× 13 0.3× 22 0.4× 31 0.7× 23 437
Yiheng Liu China 9 94 0.5× 23 0.4× 23 0.5× 20 0.4× 36 0.9× 40 351
Tong Lin China 12 159 0.9× 14 0.2× 19 0.4× 31 0.6× 40 1.0× 45 461
Lulan Li China 9 138 0.8× 20 0.3× 34 0.7× 13 0.3× 38 0.9× 17 452
Yunyun Wang China 8 129 0.7× 52 0.8× 13 0.3× 22 0.4× 22 0.5× 11 417
Shenglong Chen China 14 181 1.0× 116 1.8× 8 0.2× 20 0.4× 65 1.5× 43 562
Feng Shen China 13 96 0.5× 30 0.5× 7 0.1× 30 0.6× 84 2.0× 61 493

Countries citing papers authored by Chao Hu

Since Specialization
Citations

This map shows the geographic impact of Chao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Hu more than expected).

Fields of papers citing papers by Chao Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Hu. The network helps show where Chao Hu may publish in the future.

Co-authorship network of co-authors of Chao Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Hu. A scholar is included among the top collaborators of Chao Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Hu. Chao Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yuanyuan, Chao Hu, Xiaofen Xu, et al.. (2025). Jiedu Quyu Ziyin prescription alleviated renal injury in MRL/lpr by inhibiting PPP-mediated oxidative stress through regulating p53/G6PD/NOX pathway. Journal of Ethnopharmacology. 355(Pt A). 120307–120307.
2.
Chen, Zhe, Chao Hu, Tianyue Zheng, et al.. (2024). ISAC-Fi: Enabling Full-Fledged Monostatic Sensing Over Wi-Fi Communication. 1. 139–153. 4 indexed citations
3.
Hu, Chao, Cao Chen, Liping Gao, et al.. (2024). Different reactive profiles of calmodulin in the CSF samples of Chinese patients of four types of genetic prion diseases. Frontiers in Molecular Neuroscience. 17. 1341886–1341886. 1 indexed citations
4.
Hu, Chao, Mengjing Li, Wei Cheng, et al.. (2024). AIM2 regulates autophagy to mitigate oxidative stress in aged mice with acute liver injury. Cell Death Discovery. 10(1). 107–107. 14 indexed citations
5.
Liu, Jian, Hui Yang, Chao Hu, et al.. (2024). Microbiome Metabolomic Analysis of the Anxiolytic Effect of Baihe Dihuang Decoction in a Rat Model of Chronic Restraint Stress. Drug Design Development and Therapy. Volume 18. 2227–2248.
6.
Chen, Cao, Chao Hu, A Ruhan, et al.. (2024). Aberrance of GAP43/p-GAP43 Closely Associates with the Pathology of Neuron Loss in Prion-Infected Rodent Models. Molecular Neurobiology. 62(4). 4435–4451. 1 indexed citations
8.
Chen, Cao, Chao Hu, Weiwei Zhang, et al.. (2023). Abnormal Changes of IL3/IL3R and Its Downstream Signaling Pathways in the Prion-Infected Cell Line and in the Brains of Scrapie-Infected Rodents. Molecular Neurobiology. 61(12). 9756–9775. 2 indexed citations
9.
Fan, Qin, Kang Xiao, A Ruhan, et al.. (2023). Accumulation of Prion Triggers the Enhanced Glycolysis via Activation of AMKP Pathway in Prion-Infected Rodent and Cell Models. Molecular Neurobiology. 61(12). 9810–9834. 2 indexed citations
10.
Hu, Chao, et al.. (2022). Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects. Clinical Drug Investigation. 42(7). 623–630. 3 indexed citations
11.
Hu, Chao, Cao Chen, Ying Xia, et al.. (2022). Different Aberrant Changes of mGluR5 and Its Downstream Signaling Pathways in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents. Frontiers in Cell and Developmental Biology. 10. 844378–844378. 6 indexed citations
12.
Hu, Chao, et al.. (2021). Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases. Frontiers in Aging Neuroscience. 13. 664965–664965. 33 indexed citations
14.
Hu, Chao, Xiaofeng Ou, Ying Wang, et al.. (2021). Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects: A Phase 1 Trial. Advances in Therapy. 38(11). 5484–5500. 57 indexed citations
15.
Shi, Qi, Cao Chen, Kang Xiao, et al.. (2021). Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease. Neuroscience Bulletin. 37(11). 1570–1582. 14 indexed citations
16.
Gao, Hongwei, Naixin Kang, Chao Hu, et al.. (2020). Ginsenoside Rb1 exerts anti-inflammatory effects in vitro and in vivo by modulating toll-like receptor 4 dimerization and NF-kB/MAPKs signaling pathways. Phytomedicine. 69. 153197–153197. 101 indexed citations
17.
Chen, Jia, Cao Chen, Chao Hu, et al.. (2020). IP10, KC and M-CSF Are Remarkably Increased in the Brains from the Various Strains of Experimental Mice Infected with Different Scrapie Agents. Virologica Sinica. 35(5). 614–625. 7 indexed citations
18.
Chen, Cao, Chao Hu, Qi Shi, et al.. (2019). Profiles of 14-3-3 and Total Tau in CSF Samples of Chinese Patients of Different Genetic Prion Diseases. Frontiers in Neuroscience. 13. 934–934. 10 indexed citations
19.
Hu, Chao, Chen Cao, Jia Chen, et al.. (2019). The low levels of nerve growth factor and its upstream regulatory kinases in prion infection is reversed by resveratrol. Neuroscience Research. 162. 52–62. 11 indexed citations
20.
Chen, Cao, Yan Lv, Chao Hu, et al.. (2019). Alternative complement pathway is activated in the brains of scrapie-infected rodents. Medical Microbiology and Immunology. 209(1). 81–94. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026